Kat6b Mouse (-)-epigallocatechin 3-gallate multiple interactions ISO KAT6B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT6B mRNA CTD PMID:22079256 Kat6b Mouse (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of KAT6B mRNA; Nicotine affects the reaction more ... CTD PMID:20230807 Kat6b Mouse 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of KAT6B mRNA CTD PMID:28960355 Kat6b Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1,2-Dimethylhydrazine results in decreased expression of KAT6B mRNA CTD PMID:22206623 Kat6b Mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression EXP 6480464 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of KAT6B mRNA CTD PMID:20230807 Kat6b Mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of KAT6B mRNA; Nicotine affects the reaction more ... CTD PMID:20230807 Kat6b Mouse 17beta-estradiol decreases expression ISO Kat6b (Rattus norvegicus) 6480464 Estradiol results in decreased expression of KAT6B mRNA CTD PMID:32145629 Kat6b Mouse 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KAT6B mRNA CTD PMID:39298647 Kat6b Mouse 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO KAT6B (Homo sapiens) 6480464 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KAT6B mRNA CTD PMID:23146750 Kat6b Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KAT6B mRNA CTD PMID:21570461 Kat6b Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin affects the methylation of KAT6B intron] which results in decreased expression of KAT6B mRNA CTD PMID:33017471 Kat6b Mouse 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of KAT6B mRNA CTD PMID:39298647 Kat6b Mouse 4,4'-sulfonyldiphenol multiple interactions ISO Kat6b (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Kat6b Mouse adefovir pivoxil decreases expression ISO KAT6B (Homo sapiens) 6480464 adefovir dipivoxil results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of KAT6B mRNA CTD PMID:19770486 Kat6b Mouse aflatoxin B1 increases methylation ISO KAT6B (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of KAT6B intron CTD PMID:30157460 Kat6b Mouse aflatoxin B1 decreases methylation ISO KAT6B (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of KAT6B gene CTD PMID:27153756 Kat6b Mouse aldehydo-D-glucose multiple interactions EXP 6480464 [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA CTD PMID:22951486 Kat6b Mouse all-trans-retinoic acid increases expression ISO KAT6B (Homo sapiens) 6480464 Tretinoin results in increased expression of KAT6B mRNA CTD PMID:23724009 Kat6b Mouse antirheumatic drug increases expression ISO KAT6B (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of KAT6B mRNA CTD PMID:24449571 Kat6b Mouse aristolochic acid A decreases expression ISO KAT6B (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of KAT6B mRNA CTD PMID:33212167 Kat6b Mouse arsane multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse arsenic atom multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse arsenite(3-) multiple interactions ISO KAT6B (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to KAT6B mRNA] CTD PMID:32406909 Kat6b Mouse arsenous acid increases expression ISO KAT6B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of KAT6B mRNA CTD PMID:20458559 Kat6b Mouse arsenous acid decreases expression ISO KAT6B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of KAT6B mRNA CTD PMID:15761015 Kat6b Mouse atrazine affects methylation ISO Kat6b (Rattus norvegicus) 6480464 Atrazine affects the methylation of KAT6B gene CTD PMID:28931070|PMID:35440735 Kat6b Mouse benzo[a]pyrene increases mutagenesis ISO KAT6B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased mutagenesis of KAT6B gene CTD PMID:25435355 Kat6b Mouse benzo[a]pyrene affects methylation ISO KAT6B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of KAT6B intron CTD PMID:30157460 Kat6b Mouse benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of KAT6B intron CTD PMID:27901495 Kat6b Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of KAT6B mRNA CTD PMID:22228805 Kat6b Mouse benzo[a]pyrene diol epoxide I affects expression ISO KAT6B (Homo sapiens) 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of KAT6B mRNA CTD PMID:20382639 Kat6b Mouse bisphenol A affects expression ISO Kat6b (Rattus norvegicus) 6480464 bisphenol A affects the expression of KAT6B mRNA CTD PMID:25181051|PMID:30816183 Kat6b Mouse bisphenol A multiple interactions ISO Kat6b (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Kat6b Mouse bisphenol A multiple interactions ISO KAT6B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of KAT6B gene CTD PMID:31601247 Kat6b Mouse bisphenol A decreases methylation ISO KAT6B (Homo sapiens) 6480464 bisphenol A results in decreased methylation of KAT6B gene CTD PMID:31601247 Kat6b Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KAT6B mRNA CTD PMID:33221593 Kat6b Mouse bisphenol A decreases expression ISO Kat6b (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of KAT6B mRNA CTD PMID:32145629|PMID:34947998 Kat6b Mouse bisphenol A increases expression ISO KAT6B (Homo sapiens) 6480464 bisphenol A results in increased expression of KAT6B mRNA CTD PMID:29275510 Kat6b Mouse bisphenol F multiple interactions ISO Kat6b (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Kat6b Mouse bleomycin A5 decreases expression ISO KAT6B (Homo sapiens) 6480464 bleomycetin results in decreased expression of KAT6B mRNA CTD PMID:21040473 Kat6b Mouse bortezomib decreases expression ISO KAT6B (Homo sapiens) 6480464 Bortezomib results in decreased expression of KAT6B mRNA CTD PMID:20977926 Kat6b Mouse butanal decreases expression ISO KAT6B (Homo sapiens) 6480464 butyraldehyde results in decreased expression of KAT6B mRNA CTD PMID:26079696 Kat6b Mouse Butylbenzyl phthalate increases methylation EXP 6480464 butylbenzyl phthalate results in increased methylation of KAT6B intron CTD PMID:28392331 Kat6b Mouse cadmium dichloride decreases expression ISO KAT6B (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse caffeine affects phosphorylation ISO KAT6B (Homo sapiens) 6480464 Caffeine affects the phosphorylation of KAT6B protein CTD PMID:35688186 Kat6b Mouse carbamazepine affects expression ISO KAT6B (Homo sapiens) 6480464 Carbamazepine affects the expression of KAT6B mRNA CTD PMID:24752500 Kat6b Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of KAT6B mRNA CTD PMID:25554681 Kat6b Mouse chloroacetaldehyde decreases expression ISO KAT6B (Homo sapiens) 6480464 chloroacetaldehyde results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Kat6b Mouse cidofovir anhydrous decreases expression ISO KAT6B (Homo sapiens) 6480464 Cidofovir results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse cisplatin decreases expression ISO KAT6B (Homo sapiens) 6480464 Cisplatin results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse clothianidin decreases expression ISO KAT6B (Homo sapiens) 6480464 clothianidin results in decreased expression of KAT6B mRNA CTD PMID:31626844 Kat6b Mouse D-glucose multiple interactions EXP 6480464 [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA CTD PMID:22951486 Kat6b Mouse diarsenic trioxide decreases expression ISO KAT6B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of KAT6B mRNA CTD PMID:15761015 Kat6b Mouse diarsenic trioxide increases expression ISO KAT6B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of KAT6B mRNA CTD PMID:20458559 Kat6b Mouse Dibutyl phosphate affects expression ISO KAT6B (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of KAT6B mRNA CTD PMID:37042841 Kat6b Mouse diclofenac affects expression ISO KAT6B (Homo sapiens) 6480464 Diclofenac affects the expression of KAT6B mRNA CTD PMID:24752500 Kat6b Mouse dicrotophos increases expression ISO KAT6B (Homo sapiens) 6480464 dicrotophos results in increased expression of KAT6B mRNA CTD PMID:28302478 Kat6b Mouse dioxygen increases expression ISO KAT6B (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse dorsomorphin multiple interactions ISO KAT6B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6b Mouse doxorubicin decreases expression ISO KAT6B (Homo sapiens) 6480464 Doxorubicin results in decreased expression of KAT6B mRNA CTD PMID:29803840 Kat6b Mouse entinostat decreases expression ISO KAT6B (Homo sapiens) 6480464 entinostat results in decreased expression of KAT6B mRNA CTD PMID:27188386 Kat6b Mouse folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Kat6b Mouse formaldehyde decreases expression ISO KAT6B (Homo sapiens) 6480464 Formaldehyde results in decreased expression of KAT6B mRNA CTD PMID:20655997 Kat6b Mouse FR900359 increases phosphorylation ISO KAT6B (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of KAT6B protein CTD PMID:37730182 Kat6b Mouse fulvestrant multiple interactions ISO KAT6B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of KAT6B gene CTD PMID:31601247 Kat6b Mouse gallic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 Gallic Acid results in decreased expression of KAT6B mRNA CTD PMID:34408198 Kat6b Mouse glucose multiple interactions EXP 6480464 [Glucose co-treated with INS1 protein] affects the expression of KAT6B mRNA CTD PMID:22951486 Kat6b Mouse ifosfamide decreases expression ISO KAT6B (Homo sapiens) 6480464 Ifosfamide results in decreased expression of KAT6B mRNA CTD PMID:25596134 Kat6b Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Kat6b Mouse manganese atom multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse manganese(0) multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse manganese(II) chloride multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse methoxychlor affects methylation ISO Kat6b (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of KAT6B gene CTD PMID:35440735 Kat6b Mouse N,N-diethyl-m-toluamide multiple interactions ISO Kat6b (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KAT6B gene CTD PMID:33148267 Kat6b Mouse nickel atom decreases expression ISO KAT6B (Homo sapiens) 6480464 Nickel results in decreased expression of KAT6B mRNA CTD PMID:25583101 Kat6b Mouse nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of KAT6B mRNA; Nicotine affects the reaction more ... CTD PMID:20230807 Kat6b Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Kat6b Mouse paracetamol increases expression ISO KAT6B (Homo sapiens) 6480464 Acetaminophen results in increased expression of KAT6B mRNA CTD PMID:26690555 Kat6b Mouse perfluorohexanesulfonic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of KAT6B mRNA CTD PMID:25812627 Kat6b Mouse perfluorononanoic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of KAT6B mRNA CTD PMID:25812627 Kat6b Mouse perfluorooctane-1-sulfonic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of KAT6B mRNA CTD PMID:25812627 Kat6b Mouse perfluorooctanoic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of KAT6B mRNA CTD PMID:25812627 Kat6b Mouse permethrin multiple interactions ISO Kat6b (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KAT6B gene CTD PMID:33148267 Kat6b Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of KAT6B mRNA CTD PMID:23091169 Kat6b Mouse PhIP increases expression ISO KAT6B (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of KAT6B mRNA CTD PMID:20816883 Kat6b Mouse picoxystrobin decreases expression ISO KAT6B (Homo sapiens) 6480464 picoxystrobin results in decreased expression of KAT6B mRNA CTD PMID:33512557 Kat6b Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of KAT6B mRNA CTD PMID:20813756 Kat6b Mouse potassium chromate decreases expression ISO KAT6B (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of KAT6B mRNA CTD PMID:22079256 Kat6b Mouse potassium chromate multiple interactions ISO KAT6B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT6B mRNA CTD PMID:22079256 Kat6b Mouse pyrimidifen decreases expression ISO KAT6B (Homo sapiens) 6480464 pyrimidifen results in decreased expression of KAT6B mRNA CTD PMID:33512557 Kat6b Mouse sarin decreases expression ISO KAT6B (Homo sapiens) 6480464 Sarin results in decreased expression of KAT6B mRNA CTD PMID:19522546 Kat6b Mouse sarin increases expression ISO KAT6B (Homo sapiens) 6480464 Sarin results in increased expression of KAT6B mRNA CTD PMID:19522546 Kat6b Mouse SB 431542 multiple interactions ISO KAT6B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6b Mouse sodium arsenite decreases expression ISO KAT6B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of KAT6B mRNA CTD PMID:28595984|PMID:34032870 Kat6b Mouse sodium arsenite multiple interactions ISO KAT6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Kat6b Mouse sodium arsenite increases expression ISO KAT6B (Homo sapiens) 6480464 sodium arsenite results in increased expression of KAT6B mRNA CTD PMID:38568856 Kat6b Mouse sodium arsenite affects expression ISO KAT6B (Homo sapiens) 6480464 sodium arsenite affects the expression of KAT6B mRNA CTD PMID:29319823 Kat6b Mouse tetrachloromethane decreases expression ISO Kat6b (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of KAT6B mRNA CTD PMID:33387578 Kat6b Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of KAT6B gene; titanium dioxide results in decreased methylation more ... CTD PMID:35295148 Kat6b Mouse titanium dioxide increases methylation EXP 6480464 titanium dioxide results in increased methylation of KAT6B gene CTD PMID:35295148 Kat6b Mouse trichostatin A decreases expression ISO KAT6B (Homo sapiens) 6480464 trichostatin A results in decreased expression of KAT6B mRNA CTD PMID:24935251|PMID:26272509|PMID:28542535 Kat6b Mouse trichostatin A multiple interactions ISO KAT6B (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6b Mouse triphenyl phosphate affects expression ISO KAT6B (Homo sapiens) 6480464 triphenyl phosphate affects the expression of KAT6B mRNA CTD PMID:37042841 Kat6b Mouse triptonide increases expression EXP 6480464 triptonide results in increased expression of KAT6B mRNA CTD PMID:33045310 Kat6b Mouse valproic acid affects expression ISO KAT6B (Homo sapiens) 6480464 Valproic Acid affects the expression of KAT6B mRNA CTD PMID:25979313 Kat6b Mouse valproic acid decreases expression ISO KAT6B (Homo sapiens) 6480464 Valproic Acid results in decreased expression of KAT6B mRNA CTD PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 Kat6b Mouse valproic acid multiple interactions ISO KAT6B (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6b Mouse vinclozolin affects expression ISO Kat6b (Rattus norvegicus) 6480464 vinclozolin affects the expression of KAT6B mRNA CTD PMID:19015723 Kat6b Mouse vorinostat decreases expression ISO KAT6B (Homo sapiens) 6480464 vorinostat results in decreased expression of KAT6B mRNA CTD PMID:27188386